Robert J. Hombach insider trades
Open-market stock purchases and sales by Robert J. Hombach, Director at Embecta Corp, from SEC Form 4 filings since Sep 1, 2010.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +22%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 12, 2026 | EMBC Embecta Corp | Bought | $224K |
| Jun 22, 2026 | SPTX Seaport Therapeutics, Inc | Bought | $236K |
| Jun 2, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
| Apr 30, 2026 | SPTX Seaport Therapeutics, Inc | Bought (not open market) | — |
| Mar 6, 2026 | HSIC Henry Schein Inc | Bought (not open market) | — |
| Feb 11, 2026 | EMBC Embecta Corp | Bought (not open market) | — |
Companies traded
- EMBC Embecta Corp: 1 buy, last Aug 12, 2026
- SPTX Seaport Therapeutics, Inc: 1 buy, last Jun 22, 2026
- BMRN Biomarin Pharmaceutical Inc: other filings, last Jun 2, 2026
- HSIC Henry Schein Inc: other filings, last Mar 6, 2026
- APTX Aptinyx Inc: 9 buys, last May 26, 2022
- KMX CarMax Inc: other filings, last Jul 2, 2021
- BXLT Baxalta Inc: other filings, last Jun 3, 2016
- BAX Baxter International Inc: 1 sale, last Mar 3, 2015